RIO DE JANEIRO (AP) – President Jair Bolsonaro unveiled rules Wednesday expanding the prescription of chloroquine, the predecessor of an anti-malaria drug promoted by U.S. President Donald Trump, for coronavirus patients despite a lack of clinical proof that it is effective.
Chloroquine was already being used in Brazil for COVID-19 patients who are hospitalized in serious condition, and under the new regulations, it can be given to people with lighter symptoms such as abdominal pain, cough or fever, according to the Health Ministry.
“There is still no scientific evidence, but it is being monitored and used in Brazil and worldwide,” Bolsonaro, who has likened the virus to a “little flu” and feuded with local governments over their stay-at-home measures, said via his official Facebook page. “We are at war: ‘Worse than being defeated is the shame of not having fought.'”
More than 291,000 coronavirus cases have been confirmed in Brazil, the third most in the world after the United States and Russia, and the announcement came a day after the country’s single-day death toll from the virus hit a new high of more than 1,100. Officials said Wednesday that 888 more died in the subsequent 24 hours.
Trump has promoted treating COVID-19 with hydroxychloroquine, a variant considered less toxic and more effective than chloroquine, and he announced Monday that he was taking the drug as a precaution. No large, rigorous studies have found either drug safe or effective for preventing or treating the virus.